FDA Approved: DEFERASIROX — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's generic deferasirox (DEFERASIROX) for the treatment of chronic iron overload due to blood transfusions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Chronic Blood Transfusions

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)